The incidence of malignant melanoma is increasing annually in Canada and patients present to nondermatologist groups (NDGs) first to have suspicious lesions examined.
Objective:
To determine the ability of Canadian NDGs in the recognition and management of melanoma.
Methods:
A survey of 25 malignant and benign skin lesion photographs was distributed to dermatologists and NDGs across Canada. Participants were asked to list whether the lesions were malignant or benign, and could answer ‘uncertain’ if needed. Dermatologists were subsequently asked if they would biopsy the lesion, whereas NDGs were asked if they would biopsy/refer.
Results:
Dermatologists achieved mean sensitivities, specificities, and diagnostic accuracies of 0.79, 0.77, and 0.71, respectively. They consistently decided to biopsy malignant lesions. NDGs attained mean scores of 0.61, 0.62, and 0.53, respectively, and selected to refer/biopsy the majority of lesions, malignant and benign.
Conclusions:
NDGs should receive more dermatologic training in the recognition of malignant melanoma.
Get full access to this article
View all access options for this article.
References
1.
Canadian Cancer Encyclopaedia.Skin - melanoma. Available at: http://info.cancer.ca/cce-ecc/default.aspx?Lang=E&toc=46 (accessed December 14, 2010).
2.
MD Consult. Melanoma. Available at: http://www.mdconsult.com/das/pdxmd/body/213589136–2/0?type=med&eid=9-u1.0-_1_mt_1014668&tab=M (accessed November 1, 2010).
3.
KohH, LewR, GellerA. Skin cancer: prevention and control. In: GreenwaldP, KramerB, WeedD, editors. Cancer prevention and control. New York: Marcel Dekker;1995. p. 611-40.
4.
MarksR.Skin cancer control in Australia: the balance between primary prevention and early detection. Arch Dermatol1995;131:131-474, doi:10.1001/archderm.131.4.474.
5.
NIH Consensus Development Panel on Early Melanoma. Diagnosis and treatment of early melanoma. JAMA 1992;268:268-1314, doi:10.1001/jama.1992.03490100112037.
6.
KohH, GellerA, MillerD. Prevention and early detection strategies for melanoma and skin cancer. Arch Dermatol1996;132:132-436, doi:10.1001/archderm.1996.03890280098014.
7.
MarghoobAA, SladeJ, SalopekTG. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: screening implications. Cancer Suppl1995;75:75-707.
8.
ReintgenD, CruseCW, WellsK. The effectiveness of skin cancer screening and continuing medical education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol1992;1:1-379, doi:10.1016/0960-7404(92)90039-N.
9.
BalchCM, SoongSJ, ShawHM. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: BalchCM, HoughtonAN, MiltonGW, editors. Cutaneous melanoma. 2nd ed. Philadelphia, PA: JB Lippincott; 1992. p. 165-87.
10.
HowellJB.Spotting sinister spots. J Am Acad Dermatol1986;15:15-722, doi:10.1016/S0190-9622(86)70227-2.
11.
FriedmanRJ, RigelDS, KopfAW.Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin1985;35:35-130, doi:10.3322/canjclin.35.3.130.
12.
JemalA, SiegelR, WardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:59-225, doi:10.3322/caac.20006.
13.
GellerA, SwetterSM, BrooksK. Screening, early detection, and trends for melanoma: current status (2000–2006) and future directionsJ Am Acad Dermatol2007;57:57-555, doi:10.1016/j.jaad.2007.06.032.
14.
BurtonRC, HoweC, AdamsonL. General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen1998;5:5-156.
15.
CassilethBR, Clark WH Jr, LuskEJ. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol1986;14:14-555, doi:10.1016/S0190-9622(86)70068-6.
16.
DolanNC, MartinGJ, RobinsonJK, RademakerAW.Skin cancer control practices among physicians in a university general medicine practice. J Gen Intern Med1995;10:10-515, doi:10.1007/BF02602405.
17.
FedermanD, HoganD, TaylorJR. A comparison of diagnosis, evaluation, and treatment of patients with dermatologic disorders. J Am Acad Dermatol1995;32:32-726, doi:10.1016/0190-9622(95)91449-8.
18.
GerbertB, MaurerT, BergerT. Primary care physicians as gatekeepers in managed care: primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. Arch Dermatol1996;132:132-1030, doi:10.1001/archderm.1996.03890330044008.
19.
McGeeR, ElwoodM, AdamH. The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. N Z Med J1994;107:107-287.
20.
PaineSL, CockburnJ, NoySM, MarksR.Early detection of skin cancer: knowledge, preceptions, and practices of general practitioners in Victoria. Med J Aust1994;161:161-188;192–5.
21.
RamsayDL, FoxAB.The ability of primary care physicians to recognize the common dermatoses. Arch Dermatol1981;117:117-620, doi:10.1001/archderm.1981.01650100022020.
22.
SolomonBA, CollinsR, SilverbergNB, GlassAT.Quality of care: issue or oversight in health care reform? J Am Acad Dermatol1996;34:34-601, doi:10.1016/S0190-9622(96)80058-2.
23.
Whitaker-WorthDL.Clinical dermatologic education and the diagnostic acumen of medical students and primary care residents. Int J Dermatol1998;37:37-855, doi:10.1046/j.1365-4362.1998.00537.x.
24.
BrochezL, VerhaegheE, BleyenL, NaeyaertJM.Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions. J Am Acad Dermatol2001;44:44-979, doi:10.1067/mjd.2001.113442.
25.
ChenSC, PennieML, KolmP. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med2006;21:21-678, doi:10.1111/j.1525-1497.2006.00462.x.
26.
MorrisonA, O'Loughlin S, PowellF.Suspected skin malignancy: a comparison of diagnoses of family practitioners and dermatologists in 493 patients. Int J Dermatol2001;40:40-104, doi:10.1046/j.1365-4362.2001.01159.x.
27.
ChenSC, BravataDM, WeilE.A comparison of dermatologists' and primary care physicians' accuracy in diagnosing melanoma. Arch Dermatol2001;137:137-1627.
28.
MacKieRM.An aid to the preoperative assessment of pigmented lesions of the skin. Br J Dermatol1971;85:85-232, doi:10.1111/j.1365-2133.1971.tb07221.x.
29.
PehambergerH, BinderM, SteinerA, WolffK.In vivo epiluminescence microscopy: improvement in the early diagnosis of melanoma. J Invest Dermatol1993;100 Suppl 3s:S356–62, doi:10.1038/jid.1993.63.
30.
WiseE, SingH, MooreM. Rates of skin cancer screening and prevention counseling by US medical residents. Arch Dermatol2009;145:145-1131, doi:10.1001/archdermatol.2009.242.
